emtricitabine + tenofovir disoproxil fumarate + T101 No.2

This is a combination product containing three components: - **Emtricitabine** and **tenofovir disoproxil fumarate** are antiretroviral drugs, both classified as nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs). They act by inhibiting the activity of HIV-1 reverse transcriptase, thereby blocking viral replication. - **T101 No.2** does not correspond to a known pharmaceutical ingredient in standard drug databases or literature; it may refer to an internal code, formulation identifier, or possibly another active or excipient component not widely recognized. The combination of emtricitabine and tenofovir disoproxil fumarate is commonly used for the treatment and prevention (as pre-exposure prophylaxis) of HIV infection due to their synergistic antiviral effects.

Other names

emtricitabine + tenofovir disoproxil fumarate + T101 No.2